Table 1.
Baseline Characteristics of the Study Participants
| Characteristics | IA (n = 52) | IDA (n = 43) |
|---|---|---|
| Age, median (IQR), years | 35 (26, 45) | 35 (25, 47) |
| Male sex, n (%) | 46 (88) | 38 (88) |
| Microfilaria count, geometric mean (range), Mf/mL | 190 (51–1064) | 198 (51–1498) |
| Men with worm nests/number examined (%) | 34/41 (83) | 22/32 (69) |
| Mean worm nestsa (range) | 2.5 (1-6) | 2.7 (1-7) |
| Mean ± SD FTSb | 2.75 ± 0.52 | 2.74 ± 0.48 |
| Circulating antigen, geometric mean (95% CI),c ng/mL | 25.6 (17.4–33.8) | 35.9 (22.3–49.5) |
Abbreviations: CI, confidence interval; ELISA, enzyme-linked immunosorbent assay; FTS, Filarial Test Strip; IA, ivermectin plus albendazole; IDA, ivermectin plus diethylcarbamazine plus albendazole; IQR, interquartile range; Mf, microfilaria; SD, standard deviation.
aIn men with 1 or more worm nests detected by ultrasound.
bAverage of FTS score of 1, 2, or 3.
cMeasured by ELISA using the same antibodies used for the FTS.